NuScale Power (NYSE: SMR) has shed approximately 85% of its market value since July 2025, raising questions about whether the sell-off has created a rare long-term entry point.
The company holds a unique position in the nuclear energy sector as the only advanced reactor developer with a small modular reactor design certified by the Nuclear Regulatory Commission.
That regulatory approval gives NuScale a years-long head start over competitors in an industry where licensing timelines can stretch across decades.
Despite that structural advantage, SMR technology has yet to be proven commercially viable by NuScale or any other company currently operating in the space.
The most immediate pressure on the stock is a near-complete absence of firm commercial contracts, with utility companies showing interest but stopping short of signing binding agreements.
That commercial drought has been reflected directly in the company’s financials, with revenue falling from roughly $8 million in each of the second and third quarters of 2025 to just $0.6 million in the first quarter of 2026.
The revenue collapse has rattled investor confidence, but NuScale’s most significant potential catalyst could arrive before the end of this year.
The company’s largest pipeline project, a 6-gigawatt SMR system for a major northeastern U.S. utility operator, is expected to result in a signed power purchasing agreement by the close of 2026.
A finalized PPA would contractually obligate the utility to purchase power from the facility at a set rate for potentially decades, dramatically reducing uncertainty around NuScale’s long-term commercial runway.
Such a contract would also improve NuScale’s ability to raise additional capital and pursue further development projects, creating a positive feedback loop for the business.
Bank of America has estimated the global nuclear energy opportunity at $10 trillion over the long term, a figure that underscores just how large the addressable market could become for early movers.
Even accounting for substantial execution risk and financing challenges, capturing even a modest fraction of that global market could translate into significant upside relative to NuScale’s current depressed valuation.
The stock’s steep decline, paradoxically, may be strengthening the long-term investment case by offering exposure to a first-mover nuclear platform at a fraction of its recent peak price.
If institutional skepticism toward advanced nuclear energy persists in the near term, patient investors may find additional opportunity to accumulate shares at reduced prices ahead of any commercial breakthrough.
